BanT. A.: Human pharmacology and systematic clinical studies with a new phenothiazine.Leeds Symposium on Behavioural Disorders ed. JennerF. A.Essex, Vernon Lock Ltd.,1965.
2.
ChanoitP. F., Clinical study of a new neuroleptic: propericiazine.La Presse Médicale71: 339, 1963.
3.
DanielA. B.: Neulactil (pericyazine) in the behavior disturbances of institutionalized mental defectives.S. Afr. Med. J.41: 995, 1967.
4.
GallantD. M., BishopM. P., and GallantJ. C.: A preliminary evaluation of SKF 20.716 (propericiazine) in chronic schizophrenic patients.Curro Ther. Res.6: 597, 1964.
5.
IsraelL.: Use of R.P. 8909 in hospitalized patients with character troubles.Strasbourg Medical3: 194, 1965.
6.
RaschP. J.: Treatment of disorders of character and schizophrenia by pericyazine.Acta Psychiat, Scand. Suppl.191: 200, 1966.
7.
St. JeanA.: Clinical studies with propericiazine (R.P. 8909).Dis. Nerv. Syst.28: 526, 1967.
